Pfizer appeals China's decision to deny Viagra patent

Pharmaceutical giant Pfizer said Tuesday that it has filed an appeal with Beijing's First Intermediate People's Court against China's State Intellectual Property Office decision to reject the company's Chinese patent for Viagra.

Pfizer's efforts to obtain a patent for Viagra are seen as a test of China's willingness to protect the intellectual property rights of foreign companies, following the tightening of patent protections made in order to qualify for membership in the WTO. AP has more.

 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.